Facts & figures

The Hubertus Wald Tumor Center – University Cancer Center Hamburg (UCCH) is certified as an Oncological Center by the German Cancer Society (DKG) since 2011, by the German Society for Hematology and Oncology (DGHO) since 2007. The UCCH is certified as an Oncological Center of Excellence by the German Cancer Aid (DKH) since 2009.


The goal of this coordinative network is an optimal individual tumor medical care for patients and the consistent further development of clinical and translational research in the Hamburg metropolitan region. Personalized therapy concepts are offered on the basis of molecular biological analyses. In addition to therapy and research, we look after the individual well-being of patients through numerous additional services (e.g. music, art, sports therapy, nutrition, etc.) and have also further developed prevention and aftercare concepts.

Since 2015, UCCH is the first federal state to implement the amended regional cancer register law (Hamburg) in close cooperation with the UKE Clinical Cancer Research Registry, which is coordinated by the UCCH. The Hamburg Cancer Register (HKR) was founded in 1926 and is thus the oldest of its kind in the world.


Initial certification as Breast Center at the UKE (DKG - organ cancer center)

Foundation and start of the University Cancer Center Hamburg (UCCH) and certification as an Oncological Center by the DGHO

Initial certification as Prostate Cancer Center (DKG - organ cancer center)

Honouring and first funding as an Interdisciplinary Oncology Center of Excellence by the DKH

DIN ISO 9001 certification of the whole UKE (first medical center in Germany)

Certification as a family friendly company, for patient safety and ethics criteria

Initial certification as Gynecological Cancer Center (DKG - organ cancer center) with a certified dysplasia unit since 2015

Establishment of a Central Entry Port, a central administration and an outpatient clinic for all cancer patients

Initial certification as superordinate Oncological Center (DKG) with Head-Neck Tumor Center (organ cancer center)

Second honouring and founding by the DKH as an Interdisciplinary Oncological Center of Excellence

Initial certification as Colon Cancer Center (DKG - organ cancer center)

Renewed award and start of 3rd funding period by DKH as an Interdisciplinary Oncological Center of Excellence

Initial certification of the ENETS Center for Excellence - European certification as a center of excellence for neuroendocrine tumors

Initial certification as Skin Cancer Center (DKG - organ cancer center)

Patient care

At the UCCH patients are cared for covering the whole range of oncological and hematological diseases. According to the treatment method (chemotherapy, radiation therapy, surgery etc.) patients are either treated stationary or in our outpatient department.

The UCCH consists of all major facilities necessary for the treatement of oncological and hematological patients and operates according to newest scientific findings and predefined treatment plans. One main focus lies on the personalized cancer medicine. Based on interdisciplinary tumor conferences and liaision services there is a close joint work with all cooperating departments and external partners in the metropolitian area of Hamburg.

  • 42% of all cancer patients of the UKE reach us via our central entry port
  • > 30% of all patients are trans-regional
  • Palliative medical focus at the UKE with ESMO certification, recognition by the DKG and certificate of the German Society for Palliative Medicine
  • More than 30 specialized outpatient clinics for different entities (tumors)
  • 13 specialized outpatient clinics for e.g. complementary medicine, hereditary tumors, second opinion, prevention and personalized medicine
  • Survivorship program for patients
  • Focus on psycho-oncological care and research (> 11,000 contacts each year)
  • Close cooperation with more than 38 patient support groups

The UCCH in numbers

  • > 8,300 stationary patients and > 17,400 outpatients
  • > 6,700 new diagnoses per year
  • > 17,000 patients/year visit our consultation hours and outpatient clinics
  • > 14,000 tumor cases per year are discussed in interdisciplinary tumor conferences
  • > 3,200 patients in systematic therapies each year with > 36,000 medications

    (status 2018)

Clinical studies

  • > 2,300 UCCH patients are curently enrolled in interventional clinical trials
  • Electronic tool "Trial Finder" for quick search of internal and external open studies
  • Joint study management with cooperation partners


  • Interdisciplinary research programs for Dissemination & Metastasis, Prostate Cancer, Leukemia & Lymphoma, Neuro-oncology, Psycho-oncology, Head & Neck Cancer, Gastro-intestinal Cancer and Cancer Epidemiology
  • > 25 core facilities for experimental, clinical, translational and epidemiological cancer research
  • > 1,500 publications with the "research focus cancer" (2016-18)


  • 39 evidence-based pathways for diagnostics, therapy and follow-up care
  • 21 interdisciplinary tumor boards
  • Central units: UCCH Cancer Registry, UCCH Clinical Trial Center, Central Entry Port, UCCH Core Unit (central administration)
  • Coordination of cancer-relevant bio- and tissue repositories at the UKE
  • Regular evaluation of tumor boards decisions


Around 520 physicians, researchers and clinical and administrative staff in the service of cancer medicine

Executive Board

The structure of the UCCH is divided into three hierarchical layers:
1.) UCCH Executive Board,
2.) Board Council,
3.) Meeting of Members.

UCCH Executive Board


  • Hubertus Wald Foundation
  • German Cancer Aid
  • José Carreras Foundation